Holen Sie sich die Stockscreener-App
55.63
1.40%
0.77
Handel nachbörslich:
55.46
-0.17
-0.31%
Schlusskurs vom Vortag:
$54.86
Offen:
$55.35
24-Stunden-Volumen:
3.67M
Relative Volume:
1.04
Marktkapitalisierung:
$24.66B
Einnahmen:
$2.44B
Nettoeinkommen (Verlust:
$1.36B
KGV:
29.14
EPS:
1.9093
Netto-Cashflow:
$574.14M
1W Leistung:
+3.00%
1M Leistung:
+9.53%
6M Leistung:
+46.05%
1J Leistung:
+66.61%
1-Tages-Spanne:
$54.35
$55.82
1-Wochen-Bereich:
$53.95
$56.50
52-Wochen-Spanne:
$33.40
$56.50
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
55.63 | 24.32B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
445.77 | 112.43B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
616.18 | 64.09B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.00 | 54.88B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.69 | 39.01B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
149.55 | 31.57B | 742.00K | -1.37B | -1.07B | -7.0731 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | UBS | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
RPRX: Synthetic royalties and R&D partnerships drive growth, with China and large pharma as key opportunities - TradingView
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance UK
Prudential PLC Decreases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) director receives 4,545 share unit award - Stock Titan
Royalty Pharma (RPRX) director awarded 4,545 restricted stock units in equity grant - Stock Titan
Director Ted Love receives 4,545 RSUs at Royalty Pharma (RPRX) - Stock Titan
Director at Royalty Pharma (RPRX) receives 4,545 restricted stock units grant - Stock Titan
Royalty Pharma (RPRX) director Carole Ho awarded 4,545 restricted shares - Stock Titan
Royalty Pharma (RPRX) awards 4,545 RSUs to board director - Stock Titan
Royalty Pharma (RPRX) director awarded 4,545 RSUs under 2020 equity plan - Stock Titan
Royalty Pharma (RPRX) director Bonnie Bassler awarded 4,545 RSUs, raising holdings to 78,492 shares - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week HighTime to Buy? - MarketBeat
Capital International Inc. CA Acquires 58,030 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Stock Position Increased by Brandywine Global Investment Management LLC - MarketBeat
Los Angeles Capital Management LLC Purchases 212,294 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Acquired by Capital International Ltd. CA - MarketBeat
Capital International Sarl Purchases 166,334 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by Capital International Investors - MarketBeat
Capital Group Investment Management PTE. LTD. Has $2.53 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Cash from operating activities of Royalty Pharma Plc Class A – XETR:RPD - TradingView
Operating expenses (excl. COGS) of Royalty Pharma Plc Class A – XETR:RPD - TradingView
Non-controlling/minority interest of Royalty Pharma Plc Class A – XETR:RPD - TradingView
(RPRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Norges Bank Invests $131.92 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
Royalty Pharma (RPRX) shareholders back directors, pay and share issuance powers at 2026 AGM - Stock Titan
Royalty Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Moomoo
Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by BNP Paribas Financial Markets - MarketBeat
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript - AOL.com
Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Stock Analysis: Evaluating Its 6.26% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Royalty Pharma Secures New $1.8 Billion Credit Facility - The Globe and Mail
Royalty Pharma signs $500M co-development agreement with J&J - MSN
Royalty Pharma stock hits 52-week high at 54.82 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at 54.82 USD - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX - MarketBeat
Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares - Investing.com India
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) CFO-linked entity sells 64,399 shares under 10b5-1 plan - Stock Titan
Royalty Pharma plc Enters into Revolving Credit Agreement - marketscreener.com
Royalty Pharma (NASDAQ: RPRX) renews $1.8B unsecured revolver to 2031 - Stock Titan
Royalty Pharma Plc Hits New 52-Week High of $54.74 - Markets Mojo
Royalty Pharma Plc Hits New 52-Week High at $54.63 - Markets Mojo
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships - Sahm
Affiliates file to sell RPRX shares amid recent tranche sales (NASDAQ: RPRX) - Stock Titan
10% Of This Royalty Pharma Insider's Holdings Were Sold - 富途牛牛
Responsive Playbooks and the RPRX Inflection - Stock Traders Daily
HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.17%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):